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Introduction {#sec1}
============

Chemical modifications to nucleobases play important roles in mediating fundamental biological processes ([@bib2], [@bib43], [@bib46], [@bib51]) and are regarded as hallmarks of many diseases ([@bib4], [@bib16], [@bib19]). Therefore, a detailed analysis of natural nucleobase modifications is essential for a complete understanding of genetic and epigenetic regulation ([@bib14], [@bib15], [@bib31], [@bib42]). However, a global mapping of the modified nucleobases in the genome is often missing because of the low abundance of these modifications and lack of sensitive, selective, and genome-wide detection methods ([@bib52]).

5-Formyluracil (5fU), which is present in many cells and tissues ([@bib13], [@bib36]), can be generated by exposure to UV light ([@bib6]), ionizing radiation ([@bib13], [@bib20]), Fenton-type reagents, reactive oxygen species attack ([@bib12]), or enzyme oxidation ([@bib35]). It has been reported that 5fU modification can introduce gene mispairing ([@bib53]), alter DNA structures ([@bib23]), modulate protein-DNA interactions ([@bib25], [@bib39]), and induce perturbations of DNA function ([@bib39]). Recently, 5-formylcytosine (5fC), the modified cytosine counterpart of 5fU, has been identified as a vital epigenetic modification involved in gene regulation ([@bib24], [@bib45], [@bib50]), cell differentiation, and development ([@bib48], [@bib54]). 5fU may be an oxidation product of 5-hydroxymethyluracil (5hmU) *in vivo*, and 5hmU has been identified as not only an oxidized nucleobase but also an essential epigenetic mediator that influences transcription factors, changes the physical properties of local DNA duplex in the genome, and helps in binding of chromatin remodeling proteins ([@bib21], [@bib22], [@bib34], [@bib36]). Whether 5fU also acts as an epigenetic mediator like 5fC and 5hmU remains an open question. Although many reagents such as aminothiophenol ([@bib11]), phenylenediamine ([@bib9], [@bib29], [@bib49]), hydrazine ([@bib21], [@bib28]), and indole ([@bib40]) derivatives have been utilized to selectively label 5fU, genome-wide profiling of 5fU remains a challenge owing to its low abundance in the genome. The development of an efficient, rapid, sensitive, environment-friendly, and catalyst-free method to analyze 5fU is highly desired.

Herein, we present a novel method termed fU-Seq for determining the genome-wide distribution of 5fU in mouse hippocampus and human thyroid carcinoma tissue via an azido-modified reagent that selectively labels 5fU ([Figures 1](#fig1){ref-type="fig"}A and 1B). The challenge of selective capturing and profiling 5fU is therefore addressed by employing copper-free click chemistry between azido-modified 5fU-containing genomic DNA and commercial dibenzocyclooctyne (DBCO)-modified biotin (Click Chemistry Tools). After enrichment using streptavidin-coated magnetic beads, dithiothreitol can be used to cleave the biotin linker ([@bib44]) to release the pulled down 5fU-containing genomic DNA for further next-generation sequencing (NGS).Figure 1fU-Seq, a Method that Utilizes Selective Tagging of 5fU with an Azido-Modified Reagent(A) The chemical structures of 5fU, the azido-modified reagent, DBCO derivatives, and their products.(B) Schematic illustration of fU-Seq. Genomic DNA is fragmented, sequentially labeled with azi-BIAN, conjugated to biotin for pull-down enrichment, and released following enrichment using DTT to define 5fU sites throughout the genome. NGS, next-generation sequencing.

Results {#sec2}
=======

Evaluating the Reactivity of azi-BIAN with ODN-fU {#sec2.1}
-------------------------------------------------

First, we screened for chemicals that have the ability to efficiently tag 5fU with high yield and selectivity under warm conditions, when compared with other aldehyde modifications present in DNA. We successfully identified several chemicals that reacted efficiently with 5fU ([@bib28], [@bib29], [@bib30]). The inherent chemical properties of (2-benzimidazolyl)acetonitrile (azi-BIAN) make it high selectivity for 5fU in both nucleosides and oligonucleotides. More importantly, azi-BIAN could not react with abasic site and 5fC. We thus designed an azido derivative of azi-BIAN for enriching 5fU-containing genomic DNA ([Schemes S1](#mmc1){ref-type="supplementary-material"} and [S2](#mmc1){ref-type="supplementary-material"}).

Next, we incubated a 15-mer oligodeoxyribonucleotide containing one 5fU site (ODN-5fU) with azi-BIAN in NaOAc buffer (pH 5.0) at 37°C for 6 hr. Complete conversion to the new product ODN-azi-biaU was recorded by reversed-phase (RP)-high-performance liquid chromatography (HPLC) (monitored at 260 nm) ([Figure 2](#fig2){ref-type="fig"}C). The integrity of labeled DNAs was confirmed by MALDI-TOF mass spectrometry (MS) ([Figures 2](#fig2){ref-type="fig"}D, [S2](#mmc1){ref-type="supplementary-material"}A, and S2B). In addition, enzymatically digested mononucleosides were analyzed through HPLC-MS to ensure that the reaction of 5fU yielded 5-formyl-2′-deoxyuridine and azi-BIAN adduct (azi-biaU) ([Figure S3](#mmc1){ref-type="supplementary-material"}). In control experiments, ODN-T, ODN-5hmU, ODN-5hmC, ODN-5fC, and ODN-AP (in which the 5fU site was replaced with a T, 5hmU, 5hmC, 5fC, and abasic site, respectively) were also selected to react with azi-BIAN under the same conditions. The high selectivity of azi-BIAN for 5fU was verified by RP-HPLC (monitored at 260 nm) ([Figure S1](#mmc1){ref-type="supplementary-material"}) and denaturing polyacrylamide gel electrophoresis analysis ([Figures 2](#fig2){ref-type="fig"}A and 2B), indicating that the substitution of 5fU with 5fC or an abasic site containing aldehydes did not disturb selective labeling of 5fU by azi-BIAN. To manifest whether the oxidative damage occurs during sample workup, ODN-5fC was incubated with azi-BIAN and then the mixture was subjected to DNA MALDI-TOF MS analysis. No mass spectra of ODN-azi-biaU appeared ([Figure S4](#mmc1){ref-type="supplementary-material"}B). Meanwhile, the model DNA (80 bp double-stranded \[ds\] ODN-fC) was subjected to extraction by DNeasy Blood & Tissue Kit for simulating the process of genomic DNA extraction. After that, the extracted DNA was digested for liquid chromatography (LC)-MS analysis. No 5fU peaks was found ([Figure S5](#mmc1){ref-type="supplementary-material"}). These results indicated that the oxidative damage did not occur during sample workup.Figure 2azi-BIAN Selectively Labels and Enriches 5fU(A) PAGE analysis of ODN-5fU after incubation with azi-BIAN (lane 3) (dashed line) after being stained with nucleic acid stains (fluorescence mode, λ~ex~: 532 nm) when compared with other control DNAs such as ODN-T (lane 1), ODN-5hmU (lane 2), ODN-5hmC (lane 4), ODN-5fC (lane 5), and ODN-AP (lane 6) under the same conditions.(B) PAGE analysis of ODN-5fU after incubation with azi-BIAN and reaction with DBCO-biotin (lane 3) (dash line) after being stained with nucleic acid stains (fluorescence mode, λ~ex~: 532 nm) when compared with other control DNAs such as ODN-T (lane 1), ODN-5hmU (lane 2), ODN-5hmC (lane 4), ODN-5fC (lane 5), and ODN-AP (lane 6) under the same conditions.(C) RP-HPLC trace (260 nm) of ODN-5fU (black line); ODN-azi-biaU (blue line), which was generated by reaction with azi-BIAN; and ODN-azi-biaU, which was further labeled with DBCO-S-S-PEG3-bitoin (ODN-biotin-U, red line).(D) MALDI-TOF-spectra of ODN-5fU, ODN-5fU after incubation with azi-BIAN, and ODN-5fU after incubation with azi-BIAN and reaction with DBCO-biotin.(E) Enrichment tests of a single pool of spike-in amplicons containing 5fU, 5fC, or only canonical nucleobases, using fU-Seq. Values shown are fold enrichment over canonical nucleobases. Data are represented as mean ± SD of biological triplicate.

Enriching 5fU-Containing DNA Fragments {#sec2.2}
--------------------------------------

Besides the advantage of 5fU selective labeling, the labeled 5fU containing biotin can be used to enrich DNA fragments bearing 5fU. Because most biological samples bearing 5fU are in ds form, it was also vital to determine whether azi-BIAN selectively labels 5fU in dsDNAs. Therefore, we used a series of 80 bp dsDNAs (containing two 5fC or 5fU sites per strand or only canonical nucleosides) as a test of specificity under conditions described previously ([@bib9]) to evaluate the enrichment efficiency. These ODNs were made to react with azi-BIAN followed by biotinylation. fU-DNA was enriched over C-DNA by ∼157-fold with azi-BIAN, whereas fC-DNA was enriched over C-DNA by 1.1-fold, based on qPCR quantitation. These results confirmed that our pull-down method fU-Seq has specificity for enriching 5fU-containing DNA ([Figure 2](#fig2){ref-type="fig"}E). Because of NaBH~4~ can reduce 5fU to 5hmU and hydroxylamine (EtONH~2~) can react with formyl group of 5fU, we applied the 80bp-dsDNA which contain 5fU was reduced by NaBH~4~ or blocked by EtONH~2~ as the control experiments to validate the effectively enrichment on model DNA containing 5fU ([Figures S6](#mmc1){ref-type="supplementary-material"} and [S7](#mmc1){ref-type="supplementary-material"}). Taken together, these experiments demonstrate that covalent chemical labeling coupled with biotin-based affinity purification ensures accurate and comprehensive capture of 5fU-containing DNA fragments.

Genome-wide Mapping of 5fU in Mouse Hippocampal Tissues {#sec2.3}
-------------------------------------------------------

Recently, the LC-tandem MS (MS/MS) quantification results indicated that 5fU levels are slightly higher in mouse hippocampus (2×10^−6^ per nucleoside) than in other tissues ([@bib36]). Thus, we performed selective labeling of 5fU in genomic DNA isolated from mouse hippocampus. Genomic DNA from mouse hippocampus was sonicated into small fragments (∼250--450 base pairs), treated with azi-BIAN to yield azido-modified 5fU-containing genomic DNA, and labeled with DBCO-biotin to install biotin ([Figure 1](#fig1){ref-type="fig"}B). Because each step is bio-orthogonal and efficient, this protocol ensures selective labeling of most 5fU sites present in genomic DNA. The presence of the introduced biotin group was confirmed by avidin-horseradish peroxidase tagging and enhanced chemiluminescence visualization to obtain a dot in the dot blot assays ([Figure S8](#mmc1){ref-type="supplementary-material"}), and the HPLC-MS analyses of enzymatically digested mononucleosides from labeled genome DNA proved that the reaction of 5fU yielded the target product ([Figure S9](#mmc1){ref-type="supplementary-material"}).

Pull-down genomic DNA and an input control obtained from the same genomic DNA sample were subjected to high-throughput sequencing. We first removed adapter sequences in sequencing reads with cutadapt and only kept the reads with acceptable sequencing quality using FastQC to obtain clean data (version 0.11.5, Babraham Bioinformatics) ([@bib33]). Following these steps, Bowtie2 (version 1.2.1.1) ([@bib26]) was used to map the remaining reads to the reference genome of *Mus musculus* (GRCm38.p5.genome, downloaded from GENCODE) in single-end alignment mode.

To determine the pull-down efficiency, we identified the peaks with read enrichment in pull-down sample relative to the input control using HOMER (v4.9) software ([@bib10]). Using the findPeaks command with default parameters, 42,954 peaks were found across the genome, of which 39,829 peaks remained after filtering with the following criteria: fold change of pull down versus control \> 4 and p value of pull-down versus control \< 10^−5^.

A chromosome-level analysis of 5fU-enriched peaks indicated that the 5fU sites occur in a near-uniform distribution, although their presence was relatively higher in chromosomes 1 (8.28%), 2 (7.26%), and 5 (6.82%) ([Figure S10](#mmc1){ref-type="supplementary-material"}). In consideration of the difference in chromosome size, a rather higher distribution in chrM (peak number/genome size = 1.23×10^−4^) and an extremely lower distribution in chrY (peak number/genome size = 3.27×10^−8^) were found ([Figure 3](#fig3){ref-type="fig"}A). The fold change versus control for most peaks (75%) was found to fall between 6.46 and 24.47 ([Figure 3](#fig3){ref-type="fig"}B). We further examined the distribution of 5fU sites within different genomic element groups and found that 62.12% of the sites occurred in intergenic regions, 36.02% in introns, and 1.87% in other regions, including promoters, transcriptional termination sites (TTSs), and exons ([Figure 3](#fig3){ref-type="fig"}C). Enriched peaks were inspected in the Integrative Genomics Viewer (IGV) ([@bib38], [@bib47]) using the input control and pull-down data as shown in [Figure 4](#fig4){ref-type="fig"}A. We also obtained heatmaps of both the input and pull-down data ([Figure 4](#fig4){ref-type="fig"}B) with the script annotatePeaks.pl, from which the pull-down efficiency could be calculated. This result was also further confirmed by qPCR ([Figure S11](#mmc1){ref-type="supplementary-material"}). These results indicated that the selective enrichment of 5fU in genome by the fU-Seq strategy is effective.Figure 3The 5fU Peak Distribution in Mouse Hippocampal Tissues(A) Normalized to chromosome size at the whole-genome level.(B) Box chart of 5fU distribution based on fold change versus control. ![](fx2.gif) is the maximum value, equal to 309.98; ![](fx3.gif) is minimum value, equal to 4.08; ![](fx4.gif) is the 99% value, equal to 97.87; ![](fx5.gif) is the 1% value, equal to 4.82; and ![](fx6.gif) is the mean, equal to 15.96; the box stands for interquality (12.5%--87.5%) area, ranging from 6.46 to 24.47; the red line within is the median, equal to 10.71; upper split line is the 95% point, equal to 44.87; and lower split line is the 5% point, equal to 5.61.(C) Percentage of 5fU peak lengths overlapping with genomic features.Figure 4fU-Seq Reveals 5fU Maps in the Whole Genome of Mouse Hippocampal Tissues(A) Visual representation of the enrichment peak coverage of fU-Seq (below) and the input control (above) are shown.(B) Heatmap representations of 5fU-normalized read densities (reads/million/base) across the genome. 5fU-containing read signals across the genome ranked by Reads Per Kilobase per Million mapped reads (RPKM) in default chromosome sort order. Heatmap scales correspond to normalized read densities.(C) Distribution patterns of 5fU with respect to H3K27me3 and H3K27ac modification sites in the cerebellum.

To speculate the potential genetic significance of 5fU on histone modifications, with the annotatePeaks.pl (-size: 4,000; -hist: 10), several major existing histone modification peak data of brain tissues in adult *M. musculus*, including H3K27ac, H3K27me3, H3K4me1, and H3K4me3 (downloaded from ENCODE database), were compared with 5fU sites. Interestingly, the appearance of 5fU sites in the genome negatively correlated with H3K27ac modification peak but positively correlated with H3K27me3 modification peak ([Figures 4](#fig4){ref-type="fig"}C and [S12](#mmc1){ref-type="supplementary-material"}). H3K27me3 is known for preventing transcription. These two histone modifications have been reported to be physiologically antagonistic. When H3K27 is trimethylated, it is tightly associated with inactive gene promoters, whereas acetylation of H3K27 is associated with active transcription ([@bib1], [@bib7]). Thus, it is reasonable to speculate that 5fU sites might also play an inhibitory role in gene transcription. Also, more efforts need to be made for testifying this speculation.

Genome-wide Mapping of 5fU in Human Thyroid Carcinoma Tissues {#sec2.4}
-------------------------------------------------------------

With the advances of new techniques for whole-genome sequencing, carcinomas are discovered to be associated with modified nucleobases. Recently, researchers found that 5fU levels are about ten 5-formyldeoxyuridine per 10^6^ nucleotides in human thyroid carcinoma tissues ([@bib18]). So exploring the distribution of 5fU in cancer tissues might be vital for understanding the relationship between diseases and 5fU. Encouraged by the results of genome-wide mapping of 5fU in mouse hippocampal tissues, we further analyzed the distribution of 5fU in human thyroid carcinoma tissues. Similarly, the genomic DNA was fragmented to 250--450 bp, labeled with azi-BIAN, and biotinylated for enrichment. The pull-down samples are applied for library construction and NGS.

To verify if the methods of fU-Seq are reproducible, two biological replicates were prepared to validate the results. Input 1 (I1) and input 2 (I2) represented the input groups, and pull down 1 (P1) and pull down 2 (P2) represented the pull-down groups. The NGS reads were aligned to the reference human genome (GRCh38.p7, downloaded from GENCODE). After overlapping the two biological replicates, about 950 peaks were identified ([Figures S13](#mmc1){ref-type="supplementary-material"} and [S14](#mmc1){ref-type="supplementary-material"}).

We next analyzed the distribution pattern of 5fU peaks along each chromosome ([Figure 5](#fig5){ref-type="fig"}A). The results show that the distribution of 5fU in human thyroid carcinoma tissues is uniform in most chromosomes. The fold change of pull-down versus control for most peaks (50%) was found to fall between 6.32 and 15.30 ([Figure 5](#fig5){ref-type="fig"}B). To locate 5fU sites within the genome, we examined the distribution of 5fU sites within different gene fragment groups and found that 54.17% of the sites occurred in intergenic segments and 43.02% in introns ([Figures 5](#fig5){ref-type="fig"}C and [S15](#mmc1){ref-type="supplementary-material"}). We then examined whether 5fU is enriched at specific types of different genomic elements. We found that 5fU is highly enriched at low_complexity and simple_repeat but is depleted at transposable elements including long terminal repeats (LTRs), short interspersed nuclear elements, and long interspersed nuclear elements ([Figure S16](#mmc1){ref-type="supplementary-material"}).Figure 5The 5fU Peaks Distribution in Human Thyroid Carcinoma Tissues(A) The average distribution of merged 5fU peak (the peaks in pull-down 1 was merged with the peaks in pull-down 2) calculated from two biological replicates normalized to chromosome size in whole-genome level, using two sets of input data (I1 and I2) as control, respectively.(B) Box chart showing the distribution of four sets of 5fU peaks calculated from two pull-down data (P1, P2) and two input data (I1, I2) based on fold change versus control. ● is the maximum value, ■ is minimum value, ◆ is mean, the box stands for interquality (25--75%) area, the line within is median, upper split line is 90% point, and lower split line is 10% point. I1, input 1; I2, input 2; P1, pull-down 1; P2, pull-down 2.(C) Percentage of 5fU peak lengths overlapping with genomic features.

Enriched peaks were visualized in the IGV using the input control and pull-down data as shown in [Figure 6](#fig6){ref-type="fig"}A. To determine the pull-down efficiency, the heatmap results were obtained ([Figures 6](#fig6){ref-type="fig"}B and [S17](#mmc1){ref-type="supplementary-material"}). We also validated the 5fU-specific enrichments observed in the peaks with qPCR ([Figure S18](#mmc1){ref-type="supplementary-material"}). All these results manifested that the selective enrichment of 5fU in genome by the fU-Seq strategy is effective. We further investigated whether 5fU in human thyroid carcinoma tissues is associated with histone modification or protein-binding sites, which has genetic significance. With the assistance of annotatePeaks.pl (-size: 4,000; -hist: 2), several major existing histone modification peak and protein-binding site data of thyroid gland tissues in adults, including H3K27ac, H3K27me3, H3K4me1, H3K4me3, POLR2A (all downloaded from ENCODE database), were compared with 5fU sites. Surprisingly, the appearance of 5fU sites in the genome negatively correlated with H3K4me1 modification peak, whereas it positively correlated with binding sites of POLR2A protein ([Figure 6](#fig6){ref-type="fig"}C). H3K4me1 is enriched at active enhancers and acts as a marker for many cell-type-specific enhancer sites ([@bib5], [@bib37], [@bib41]). Hence, it is tempting to speculate that 5fU sites in human thyroid carcinoma tissues are indicative of suppressed enhancer overactivation. Besides, a lot of researchers had reported that POLR2A encodes the largest and catalytic subunit of the RNA polymerase II complex ([@bib3], [@bib32]). Because 5fU sites act as a potential repressor, they may be distributed around POLR2A-binding sites. It is reasonable to guess that the existence of 5fU in human thyroid carcinoma may impede protein binding with DNA and then inhibit the transcription of some specific genes. Further endeavor is needed for studying the causal relationship between 5fU and cancers.Figure 6fU-Seq Reveals 5fU Maps in the Whole Genome of Human Thyroid Carcinoma Tissues(A) Visual representation of the enrichment peak coverage of fU-Seq and the input control are shown. I1, input 1; I2, input 2; P1, pull-down 1; P2, pull-down 2.(B) Heatmap representations of 5fU-normalized read densities (reads/million/base) across the genome. 5fU-containing read signals across the genome ranked by RPKM in default chromosome sort order. Heatmap scales correspond to normalized read densities.(C) The correlation between 5fU sites with H3K4me1 modification and POLR2A in human thyroid carcinoma tissues.

Discussion {#sec3}
==========

The current study developed the first selective and efficient approach (fU-Seq) to label and capture 5fU from mouse and human genomic DNA and investigated the relationship between 5fU and histone modifications. We have demonstrated the feasibility of using this method to determine the genome-wide distribution of 5fU. Intriguingly, most 5fU sites were found in intergenic regions and introns. In addition, the analysis of histone modifications and 5fU sites suggested that 5fU might play an inhibitory role in gene transcription. Also, the distribution of 5fU in human thyroid carcinoma tissues is positively correlated with binding sites of POLR2A protein, which indicates that 5fU may distributed around POLR2A-binding sites. What\'s more, recently, Zhou et al. and Tretyakova et al. reported that aldehydes present in 5fC can conjugate histone to yield DNA-protein cross-linking ([@bib17], [@bib27]). Aldehydes present in 5fU are more active than 5fC ([@bib8], [@bib9]), which might also conjugate histone to yield DNA-protein cross-linking and influence transcriptional regulation and chromatin remodeling. Although the method we proposed could not realize single-base-resolution analysis of 5fU, we believe that this goal can be realized in the future, according to the recent report of single-base-resolution detection method of 5hmU proposed by Balasubramanian\'s group ([@bib22]). Further studying and applying this method will advance our understanding of the role played by 5fU modification in genomics.

Limitations of the Study {#sec3.1}
------------------------

Although this method can profile the distribution of 5fU in genomic DNA, it does not have single-base resolution. In addition, it is unavoidable for nonspecific enrichment of DNA during pull-down process. We are currently in the process of realizing the single-base-resolution analysis of 5fU, as per the recent report by Balasubramanian\'s group ([@bib22]). Combining with the single-base-resolution analysis, the nonspecific enrichment of DNA can be ruled out.

External Data {#sec3.2}
-------------

H3K27ac (ENCSR000CCE, ENCSR000CDC, ENCSR000CDD), H3K27me3 (ENCSR000CFM), H3K4me1 (ENCSR000CCF, ENCSR000CAL, ENCSR000CAI, ENCFF710BOL), H3K4me3 (ENCSR000CAK, ENCSR000CAJ, ENCSR000CDS), and POLR2A (ENCFF079QGD) chromatin immunoprecipitation sequencing datasets were obtained from ENCODE Project database.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.

Data and Software Availability {#appsec1}
==============================

Sequencing data have been deposited into the Gene Expression Omnibus (GEO). The accession number is [GSE115918](ncbi-geo:GSE115918){#intref0010}.
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Document S1. Transparent Methods, Figures S1--S18, Schemes S1 and S2, and Tables S1--S5
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